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Abstract 
To explore the physiological or pathological roles of proteases, it is important to be able to 
detect and precisely localise them in a tissue, to differentiate between inactive and active 
forms, as well as to quantify and determine the nature of the enzyme that degrade a given 
substrate. Here we present a protocol for real-time gelatin zymography that is very useful for 
the detection of gelatin degrading proteases in tissue extracts. This method uses fluorescence 
labelled gelatin and therefore, we also present an easy, fast and cheap method for labelling 
gelatin with 2-Methoxy-2,4-Diphenyl-3(2H)-Furanone (MDPF). 
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Proteases cleave proteins and peptides either at the N- and C-terminal ends (exopeptidases) or 
within the polypeptide chain (endopeptidases). These enzymes exist in all living organisms 
and there is estimated to be more than 66000 different proteases [1, 2]. They are localized 
either within a cell, on or in the cell membrane, or secreted from the cell into the extracellular 
space [3]. Proteases are important for an organisms’ survival [4, 5]. Dysregulation of one or 
several proteases in humans and other vertebrates is associated with disease, and proteases are 
often involved when micro-organisms invade a host [6, 7, 8, 9]. Hence, proteases are 
important targets for therapeutic intervention [10, 11]. 
Proteases are classified into eight different classes/clans based on the amino acid or prosthetic 
group involved in the catalytic reaction. These classes are aspartic (A), cysteine (C), glutamic 
(G), metallo (M), aspargine (N), mixed (P), serine (S) and threonine (T) proteases (Merops 
database) [12]. 
There are more than 566 human and 644 murine proteases, of which 273/341 are secreted, 
277/283 are intracellular and 16/16 are intramembraneous, respectively. The majority of 
human and murine proteases are of the metallo-, serine- and cysteine type, where most of the 
metallo- and serine proteases are secreted while the cysteine proteases are mainly localized 
within the cell [3]. 
Proteases induce an irreversible change of the substrate they process. Hence, most proteases 
are tightly regulated at the transcriptional, post-transcriptional, translational and/or the post-
translational level. These enzymes are synthesised in an inactive pro-form, and are either 
activated within the cell or in the extracellular space. Once activated, their activity is 
4 
 
regulated by protease inhibitors that bind either reversibly or irreversibly to the enzyme [6, 9, 
13, 14].  
To explore the physiological or pathological roles of proteases, it is important to be able to 
detect and precisely localise them in a tissue, to differentiate between inactive and active 
forms, as well as to quantify and determine the nature of the enzyme that degrade a given 
substrate. Active proteases can be determined in tissue by in situ substrate zymography. Here 
we will present a protocol for real-time gelatin zymography, which is very useful for the 
detection of active gelatinases in tissue extracts. There are several proteases that degrade 
gelatin (denatured collagen), which include the two matrix metalloproteases MMP-2 and 
MMP-9 [15]. Other enzymes are serine proteases like trypsin, plasmin and matriptase, as well 
as cysteine proteases such as cathepsin L [16, 17, 18, 19]. In this protocol we focus on 
proteases that function around a neutral pH, but the protocol can be slightly changed for the 
detection of proteases with an optimal activity at slightly acidic pH (see Note 1). 
Proteases can be extracted from both unfixed and fixed tissue, but independent of the 
extraction method, much larger amount of proteins is extracted from unfixed tissue compared 
to fixed tissue [20]. We have previously extracted proteins from kidney, liver, tongue and 
heart tissue by mincing it in a tissue homogenizer with steel bullets in various extraction 
solutions including: 
(1) 0.25% Triton X-100 (v/v), 10 mM CaCl2 in Milli-Q water  
(2) 10% DMSO (v/v), 10 mM CaCl2 in Milli-Q water   
(3) Zymography loading buffer (1x): 0.05 M Tris-HCl, pH 6.8, 10% glycerol, 2.0 % SDS, 
0.05% bromophenol blue  
(4) 1.0 M NaCl, 10 mM CaCl2 in Milli-Q water 
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The extracted proteins can be analysed by different methods such as Western-blotting, SDS-
PAGE along with mass spectrometry or by gelatin SDS-PAGE zymography. The latter 
method reveals both the activity and the molecular size of the gelatin degrading proteases. For 
MMPs, this method detects both the inactive pro-form and the active form of the protease 
because pro-MMPs refold and auto-activate when SDS is washed away after the 
electrophoresis. During the following incubation period (usually 37 °C) proteases can degrade 
the gelatin incorporated in the SDS-gel. Even though gelatin SDS-PAGE zymography gives 
information of the gelatin degrading enzymes present in the tissue, most reversible inhibitors 
will be dissociated from the proteases during SDS-PAGE, and hence, it is not possible to 
conclude that the proteases detected are active in situ. Therefore, gelatin SDS-PAGE 
zymography and gelatin in situ zymography are complementary techniques for the 
characterization of gelatin degrading enzymes in a tissue. For both in situ and SDS-PAGE 
gelatin zymography, various types of inhibitors can be used to determine the type of protease 
responsible for the substrate degradation (see Note 2). 
When extracting gelatinolytic enzymes from a tissue, other proteins will follow.  These non-
gelatinolytic proteins can overlap and mask the gelatinolytic bands when running an ordinary 
gelatin SDS-PAGE gel. To avoid this problem, real-time SDS-PAGE zymography can be run 
instead. 
In contrast to normal gelatin zymography, real-time gelatin zymography is based on the use of 
fluorescence labelled gelatin. Thus, it is not necessary to stain the gel after electrophoresis and 
hence other proteins in an extract will not interfere with the detection of gelatinolytic 
proteases. Another advantage is that it is possible to follow the development of gelatin 
degradation in real-time by observing the gel under UV-light (see Note 3). In this protocol, we 
will describe an easy, fast and cheap method for labelling gelatin with the dye, 2-Methoxy-
2,4-Diphenyl-3(2H)-Furanone (MDPF). The dye reacts rapidly with primary amines and form 
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highly fluorescent and stable fluorophores (λex=385 nm and λem=480 nm), while the unbound 
dye and its hydrolysis products are non-fluorescent. The concentration of bound MDPF to 
gelatin can be determined from measuring the absorbance of the labelled gelatin at 385 nm, 
using the extinction coefficient, ε385nm ≈ 6500 M-1·cm-1. This protocol is based on MDPF 
labelling of triple helical collagen [21]. Figure 1 shows a comparison between real-time 
gelatin zymography using MDPF-labelled gelatin and the traditional normal gelatin 
zymography. Previously, Hattori et al. has described real-time zymography and real-time 
reverse zymography using FITC-labelled collagen, casein and BSA [22]. The real-time 
zymography method presented here using MDPF-labelled gelatin can easily be converted to 
real-time reverse gelatin zymography by simply incorporate an appropriate amount of an 
enzyme like MMP-9, MMP-2 or trypsin in the SDS-PAGE gel along with the MDPF-gelatin 
(see Note 4). We have used this real-time reverse gelatin zymography method in several of 
our studies to detect the expression of tissue inhibitors of MMPs (TIMPs) [23, 24, 25]. 
“[Fig 1 near here]” 
 
2 Materials 
2.1 Reagents and buffers 
1. Gelatin (type A, porcine skin). 
2. 2-Methoxy-2,4-Diphenyl-3(2H)-Furanone (MDPF). 
3. Acetone. 
4. Acrylamide/Bis-acrylamide (29:1) (40% solution) (see Note 5). 
5. Sodium dodecyl sulfate (SDS) (see Note 6). 
6. Bromphenol blue. 
7. N,N,N´,N´-Tetramethylethylenediamine (TEMED). 
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8. 10% ammonium persulphate (APS) in Milli-Q water (stored at 4 °C).  
9. Optional: enzyme inhibitors such as ethylenediaminetetraacetic acid (EDTA), 
Galardin, Pefabloc. 
10. 50 mM Sodium tetraborate, pH 9.0. 
11. Separating gel buffer: 1.5 M Tris-HCl, pH 8.8, 0.4% SDS (see Note 6). 
12. Stacking gel buffer: 0.5 M Tris-HCl, pH 6.8, 0.4% SDS. 
13. Electrophoresis buffer: 25 mM Tris, 190 mM Glycine, pH 8.3, 0.1% SDS. 
14. Zymography loading buffer (5x): 0.25 M Tris-HCl, pH 6.8, 50% Glycerol, 10% SDS, 
0.5% Bromphenol blue (see Note 7). 
15. Wash buffer: 2.5% Triton X-100 in Milli-Q water. 




1. Imaging system with a transilluminator (with 302 nm UV or 365 nm long wave UV) 
and a Camera with an emission filter in front of the lens. 
2. Heating cabinet (37 ºC). 
3. Vertical electrophoresis equipment with cooling. 
4. Power supply. 
5. Gel casting system for polyacrylamide gels, including glass and alumina plates with 
appropriate spacer and well-combes. 
6. Optional: Hand held UV-lamp (we use Model UVL-21, Long wave UV-366 nm; UVP 
Inc.). 
7. Optional: Converting plate with excitation filter converting UV 302 nm to UV 365 nm 
(Ultra-Violet Products LTD) 
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3.1 Labelling of gelatin with MDPF  
All solutions and steps containing MDPF should be protected from light. 
1. Dissolve 37.5 mg gelatin  in 5 mL 50 mM sodium tetraborate buffer pH 9.0. Warm the 
solution until the gelatin is dissolved, and then allow the solution to cool down to 
room temperature. Use a magnet for stirring. (To label larger amounts of gelatin, see 
Note 8). 
2. Dissolve 2 mg of 2-Methoxy-2,4-Diphenyl-3(2H)-Furanone (MDPF) in 3 mL of 
acetone.  
3. Add the MDPF solution slowly to the gelatin solution (room temperature; should take 
about 1 hr), with continuous stirring. When all MDPF is added, keep on stirring for 1 
hr at room temperature. 
4. Dialyse the labelled gelatin against 2 x 1 L of Milli-Q water at 4 °C. This is to remove 
unbound MDPF and buffer. 
5. Lyophilize the dialysed MDPF-labelled gelatin (see Note 9). 
6. Dissolve the lyophilized MDPF-labelled gelatin in 1.875 mL Milli-Q water. This gives 
a gelatin concentration of approximately 2%. 
7. Store dark in small batches. For long time storage, use a freezer. 
 
3.2 Preparation of MDPF-gelatin SDS-PAGE separating gel 
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1. The amounts given are for a separating gel with the following dimensions: (0.75 mm x 8.2 
cm x 5.5 cm), i.e. a total volume of approximately 4.5 mL for 7.5%, 10% and 13% 
polyacrylamide gels. A 7.5% gel is ideal for enzymes with a molecular size of 90 kDa or 
larger, while a 10% gel is best suited for enzymes with molecular sizes between 40 to 90 kDa 
and a 13% gel for enzymes with molecular sizes below 40 kDa (see Note 9).  
 
Solutions    PAGE 7.5%  PAGE 10%  PAGE 13% 
1: Separating gel buffer (mL) 1.12   1.12   1.12 
2: 2% MDPF-gelatin (µL)  225   225   225 
3: Milli-Q water (mL)  2.266   1.974   1.625 
4: 40% Acrylamide (mL)   0.874   1.166   1.515 
5: TEMED (µL)   7.0   7.0   7.0 
6: 10% APS (µL)   15   15   15 
 
Mix the compounds in a plastic tube. Once the TEMED and APS have been added, the 
polymerization starts. Mix carefully and load the solution between the glass and alumina plate 
in a hand cast polyacrylamide gel casting system. Put gently a thin layer of Milli-Q water at 
the top of the loaded mixture and allow the acrylamide to polymerize (15-20 min). Protect the 
polymerizing gel from light! 
 
3.3 Preparation of SDS-PAGE stacking gel 
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1. The amount is for a stacking gel with the following dimensions (0.75 mm x 8.2 cm x 2.5 
cm), i.e. a total volume of approximately 1.5 mL. We give the contents of gels with 4% and 
5% polyacrylamide. 
 
Solutions    PAGE 4%  PAGE 5% 
1: Stacking gel buffer (mL)  0.186   0.186 
2: Milli-Q water (mL)  1.145   1.106 
3: 40% Acrylamide (µL)  155   194 
4: TEMED (µL)   4.0   4.0 
5: 10% APS (µL)   8.0   8.0 
Remove the water and un-polymerised acrylamide over the separating gel. Mix the 
compounds in a plastic tube. Once the TEMED and APS have been added, the polymerization 
starts. Mix carefully and load the solution on top of the SDS-PAGE separating gel. Put a well 
forming comb on top, between the glass and alumina plate and allow the acrylamide to 
polymerize (15-20 min). If you also expect to detect gelatinases with molecular sizes larger 
than 300 kDa, include also MDPF-gelatin in the stacking gel (see Note 10). Protect from light. 
 
3.4 Electrophoresis and visualization 
1. Mount the gel-plates on the electrophoresis apparatus. 
2. Fill the lower and upper electrophoresis tray with electrophoresis buffer. 




4. Apply 8 μL of the non-heated samples and controls onto the gel.  
5. Start the cooling of the electrophoresis apparatus. 
6. Make sure that the gel is protected from light! 
7. Start the electrophoresis (constant current 20 mA/gel). 
8. Stop the electrophoresis when the tracking dye has entered the bottom of the gel. 
9. Remove the gel from the apparatus. 
10. Remove the gel from the casting plates. Use a spatula. 
11. Wash the gel 2 x 30 min in 50 mL Wash buffer (the gel must be protected from light). 
12. Add 50 mL of developing buffer (incubate at 37 ºC in dark). 
13. The degradation of gelatin can be visualised and photographed under UV light (366 or 
302 nm) at appropriate time points. Gelatinases are detected as dark bands against the 
fluorescent MDPF-gelatin background. 
 
4. Notes 
1. To detect gelatin degrading enzymes with a low pH optimum, use an 
appropriate developing buffer. O’Grady et al [21] showed that the overall 
spectral pattern and the excitation and emission maxima were the same at pH 
4.0 and 7.5. 
2. Various types of inhibitors can be included in the wash and developing buffers 
to determine the type of protease responsible for the substrate degradation. For 
instance, 10 mM EDTA will inhibit metalloproteases, 1 µM galardin 
(Gm6001) matrix metalloproteases and 1 mM Pefabloc serine proteases. In the 
case of serine proteases, the sample can be incubated for 15 min with 1 mM 
Pefabloc before the sample is mixed with 5x loading buffer and applied to the 
gel-well, as this is an irreversible inhibitor. 
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3. Ideal is to use a UV-lamp with long range UV (366 nm). However, it is also 
possible to use a UV-lamp with an excitation wavelength of 302 nm (see figure 
1 in the introduction). 
4. To perform real-time reverse gelatin zymography, add an appropriate amount 
of protease (recombinant, non-recombinant, or cell conditioned medium 
containing only the gelatin degrading protease of interest) to the separating gel 
(see method 3.2), and reduce the amount of Milli-Q water accordingly. We 
have used conditioned medium from PMA stimulated THP-1 cells which 
contained proMMP-9 (92 kDa) and TIMP-1 (28 kDa) [23, 24, 25]. To allow 
detection of TIMPs (Mr 20-28 kDa) in samples, it was necessary to perform 
pre-electrophoresis of the gel before the samples were loaded, in order to 
remove the TIMP-1 incorporated into the gel.    
5. Due to health security reasons, we use a commercial 40% Acrylamide/Bis-
acrylamide solution in the preparation of all polyacrylamide gels. 
6. Due to health security reasons, we use a commercial 20% SDS solution in the 
preparation of all buffers that contain SDS. 
7. Due to health security reasons, when we make the zymography loading buffer 
(5x) we do not weigh the SDS powder, but uses a commercial solution of 20 % 
SDS and hence it is not possible to use 50% glycerol. Instead, we use 20% 
(w/v) sucrose. 
8. For MDPF-labelling of larger amounts of gelatin, adjust the amount of 
tetraborate buffer to obtain the same concentration of gelatin as step 1 in 
method 3.1. Increase the amount of MDPF and acetone correspondingly. Also, 
adjust the volume of Milli-Q water during dialysis. 
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9. To use dialysed MDPF-gelatin that has not been lyophilized, measure the 
volume of the dialysed sample and calculate the concentration of MDPF-
gelatin. Based on this, use an appropriate volume to obtain a concentration of 
0.1% of MDPF-gelatin in the separating gel. 
10. Add 150 μL of 2% MDPF-gelatin and reduce the amount of Milli-Q water 
accordingly to get 0.2% of MDPF gelatin in the stacking gel. To avoid a dark 
zone between the separation and stacking gel due to a reduced amount of 
MDPF-gelatin, be careful to remove all water and un-polymerised acrylamide 
over the separating gel before the stacking gel is applied. 
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